Analysis of Factors Influencing Immunological Failure in Elderly People Living with HIV Undergoing Antiretroviral Therapy: A LASSO-Logistic Regression Approach.
{"title":"Analysis of Factors Influencing Immunological Failure in Elderly People Living with HIV Undergoing Antiretroviral Therapy: A LASSO-Logistic Regression Approach.","authors":"Ruilin Li, Yan Lu, Lianzhao Yang, Xiuhong Long, Xiang Luo, Dengqiang Wu, Zhanhang Zheng, Shuhong Qin, Wenting Qin, Chenxingzi Wu","doi":"10.1177/08892229251365583","DOIUrl":null,"url":null,"abstract":"<p><p>This study aimed to identify key predictors of immunological failure in elderly patients with HIV receiving antiretroviral therapy (ART) through machine learning approaches. We conducted a retrospective analysis of 490 elderly patients with HIV (including 120 with immunological failure) treated at Guigang People's Hospital from January 2009 to May 2024, using data extracted from the AIDS Comprehensive Prevention and Control Information System. Employing a two-stage analytical approach, we first applied least absolute shrinkage and selection operator (LASSO) regression to screen 50 potential risk factors, identifying 6 significant predictors. These were subsequently analyzed via logistic regression, revealing six protective factors: moderate disease stage [odds ratio (OR) = 0.401], AIDS stage (OR = 0.130), cotrimoxazole use (OR = 0.495), β2-microglobulin levels (OR = 0.755), platelet count (OR = 0.767), and alanine aminotransferase levels (OR = 0.760). Age was identified as an independent risk factor (OR = 1.275). Finally, the Shapley Additive explanations (SHAP) algorithm was utilized to rank feature importance, providing interpretable insights into predictor contributions. This study used machine learning (LASSO and logistic regression) to pinpoint critical predictors of immunological failure in elderly patients with HIV on ART, aiding early detection of high-risk individuals and informing prevention strategies.</p>","PeriodicalId":7544,"journal":{"name":"AIDS research and human retroviruses","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS research and human retroviruses","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/08892229251365583","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
This study aimed to identify key predictors of immunological failure in elderly patients with HIV receiving antiretroviral therapy (ART) through machine learning approaches. We conducted a retrospective analysis of 490 elderly patients with HIV (including 120 with immunological failure) treated at Guigang People's Hospital from January 2009 to May 2024, using data extracted from the AIDS Comprehensive Prevention and Control Information System. Employing a two-stage analytical approach, we first applied least absolute shrinkage and selection operator (LASSO) regression to screen 50 potential risk factors, identifying 6 significant predictors. These were subsequently analyzed via logistic regression, revealing six protective factors: moderate disease stage [odds ratio (OR) = 0.401], AIDS stage (OR = 0.130), cotrimoxazole use (OR = 0.495), β2-microglobulin levels (OR = 0.755), platelet count (OR = 0.767), and alanine aminotransferase levels (OR = 0.760). Age was identified as an independent risk factor (OR = 1.275). Finally, the Shapley Additive explanations (SHAP) algorithm was utilized to rank feature importance, providing interpretable insights into predictor contributions. This study used machine learning (LASSO and logistic regression) to pinpoint critical predictors of immunological failure in elderly patients with HIV on ART, aiding early detection of high-risk individuals and informing prevention strategies.
期刊介绍:
AIDS Research and Human Retroviruses was the very first AIDS publication in the field over 30 years ago, and today it is still the critical resource advancing research in retroviruses, including AIDS. The Journal provides the broadest coverage from molecular biology to clinical studies and outcomes research, focusing on developments in prevention science, novel therapeutics, and immune-restorative approaches. Cutting-edge papers on the latest progress and research advances through clinical trials and examination of targeted antiretroviral agents lead to improvements in translational medicine for optimal treatment outcomes.
AIDS Research and Human Retroviruses coverage includes:
HIV cure research
HIV prevention science
- Vaccine research
- Systemic and Topical PreP
Molecular and cell biology of HIV and SIV
Developments in HIV pathogenesis and comorbidities
Molecular biology, immunology, and epidemiology of HTLV
Pharmacology of HIV therapy
Social and behavioral science
Rapid publication of emerging sequence information.